Comparison of AVD + Low-Dose Nivolumab vs. PET-Adapted BEACOPP-like in Advanced cHL

NCT07234487 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

178

Enrollment

OTHER

Sponsor class

Conditions

Hodgkin Lymphoma

Interventions

DRUG: Nivo-AVD
DRUG: BEACOPP-like

Sponsor

St. Petersburg State Pavlov Medical University